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Background: Oral mucositis (OM) is a debilitating side-effect of chemotherapy. It has different compli-
cations, including impairment of drinking, eating and even talking, sometimes so severe that physician
stops the therapy.
Objective: Investigating the effect of Achillea millefolium distillate solution in the treatment of
chemotherapy-induced OM.
Interventions/methods: In this randomized controlled trial, 56 cancer patients with chemotherapy-
induced OM were randomly assigned into control and experimental groups in similar blocks based on
the severity of OM. The experimental group gargled 15 mL of a mixture of routine solution and distilled
A. millefolium 4 times a day for 14 days while the control group gargled 15 mL of routine solution. The
severity of OM was assessed at three times before, 7 and 14 days after intervention. Data was analyzed
using Wilcoxon, KruskaleWallis, ManneWhitney U, Friedman, Chi-square and Fisher's exact tests.
Results: The mean severity score of OM was 2.39 ± 0.875 in both groups at start of the study that was
changed to 1.07 ± 0.85 and 0.32 ± 0.54 in the intervention group in days 7 and 14 (p < 0.001). However,
the severity of OM was increased to 2.75 ± 0.87 and 2.89 ± 0.956 in the control group respectively
(p < 0.001).
Conclusions: A. millefolium distillate healed OM much more than the routine solution. Therefore, it is
suggested to be used in patients with chemotherapy-induced OM.
The study was registered in the Iranian Registry of Clinical Trials, Number: IRCT2013092214729N1.
© 2014 Elsevier Ltd. All rights reserved.Introduction
Oral mucositis (OM) refers to mucosal damage secondary to
cancer therapy occurring in the oral cavity. Mucositis can be caused
by chemotherapy and/or radiation therapy (Lalla et al., 2014). It
occurs in approximately 20%e40% of patients receiving conven-
tional chemotherapy, 80% of patients receiving high dose chemo-
therapy as conditioning for hematopoietic stem cell
transplantation, and nearly all patients receiving head and neck
radiation therapy (Avritscher et al., 2004; Lalla et al., 2014; Vera-
Llonch et al., 2007).: þ98 3615556633.
jbaghery).Pain induced by OM disturbs patients and makes it difﬁcult to
eat and drink, resulting in indigestion and dehydration (He, 2011;
Pavesi et al., 2011; Potting et al., 2006). OM can also disturb
speaking and communication with others, resulting in psycholog-
ical and social stresses (Abedipour et al., 2006). In addition, OM is
accompanied by a wide range of oral mucus alterations such as
infection and bleeding, which could result in systemic infection
(Abedipour et al., 2006; Potting et al., 2006). In severe cases, it can
increase the length of hospitalization and even lead the physician
to cease the chemotherapy (Pavesi et al., 2011; Potting et al., 2006).
A wide variety of agents have been tested to prevent OM or
reduce its severity (Yarom et al., 2013; Lalla et al., 2014). The
Mucositis Study Group of the Multinational Association of Sup-
portive Care in Cancer/International Society of Oral Oncology
(MASCC/ISOO) has published evidence based clinical practice
Fig. 1. Consort ﬂow diagram.
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evidence based patient care and improve outcomes. The current
guidelines updated in 2013 examined the evidence for the
following interventions: basic oral care, growth factors and cy-
tokines, anti-inﬂammatory agents, antimicrobials, coating
agents, anesthetics, analgesics, Laser and other light therapy,
cryotherapy, natural and miscellaneous agents (Lalla et al., 2014).
The most commonly used therapies often have no signiﬁcant
effect and sometimes cause additional side-effects (Arora et al.,
2008).
Given the side-effects of chemical drugs, complementary ther-
apies in the forms of herbal products are increasingly used all over
the world (Adib-Hajbaghery and Hoseinian, 2014).
Most of ancient civilizations used different forms of herbal
medicines. Among herbal plants, Achillea millefolium has attracted
attentions due to its wide range of therapeutic effects. It is a well
known herb from the asteraceae family, and has been extensively
used in ancient medicine for treating different diseases in general
and burns, injuries and infections in particular. One of the most
important therapeutic effects of A. millefolium is its antibacterial
effect on a wide range of pathogens (Aggarwal et al., 2011;
Saeidnia et al., 2011; Tajik and Jalali, 2009). A. millefolium fresh
ﬂowers have been used to resolve respiratory problems (Düsman
et al., 2013). It also was employed as anti-allergic (Aggarwal
et al., 2011), anti-congestion, and expectorant (Nemeth and
Bernath, 2008). Its ﬂowers' distillates contain chamazulene, cin-
eol, borneol (Orav et al., 2006), caffeic acid and salicylic acid with
antibacterial, antispasmodic and anti-inﬂammatory effects
(Aggarwal et al., 2011; Pires et al., 2009; Saeidnia et al., 2011;2005). Some ingereduants of A. millefolium also exert beneﬁcial
effects on nervous, cardiovascular and digestive systems
(Aggarwal et al., 2011). Despite historical background of this herb,
reports about its application in treatment of wounds and injuries
are rare (Tajik and Jalali, 2009). Aljancic et al. showed its signiﬁ-
cant inhibitory effect on candida albicans and bacillus subtilis in-
vitro. They also reported that, the ﬂavonoids existed in A. mil-
lefolium essence prevents the growth of aspergillus niger (Aljancic
et al., 1999).
S€okmen et al. have also studied the antimicrobial effects of A.
millefolium distillate on 12 bacterial species and 2 types of yeast.
They have reported that though its aqueous extract had no anti-
bacterial activity, the methanol one and the herb distillate had
considerable antimicrobial activity (S€okmen et al., 2004). In
another study, 32 separate ingredients have been extracted from A.
millefolium, among which Comphor and Eucalyptol have signiﬁcant
inhibitory effects on candida albicens and clostridium perfringens.
Also, Borneol and Piperitone in A. millefolium are two other com-
pounds with considerable bacterial inhibitory activity (S€okmen
et al., 2003).
During conversation with cancer patients, some revealed that
to mitigate oral wounds, they gurgle A. millefolium distillate based
on the recommendations received from some traditional groceries.
Therefore, given the anti-inﬂammatory and antimicrobial effects
of the plant, prevalence of chemotherapy-induced OM, and lack of
studies on the effects of A. millefolium on chemotherapy induced
oral muscositis, the present study was designed to investigate the
effect of A. millefolium distillate-contained solution on the
chemotherapy-induced OM.
Table 1
Demographic information of the cancer patients.a
Variable Group P value
Experimental Control
Gender >0.99f
Female 16 (57.1) 16 (57.1)
Male 12 (42.9) 12 (42.9)
Marital status 0.77f
Married 19 (67.9) 18 (64.3)
Single, Widow, Divorced 9 (32.1) 10 (35.7)
Education level 0.86f
Illiterate 14 (50) 12 (42.9)
Literate 14 (50) 16 (57.1)
Artiﬁcial teeth >0.99f
Yes 17 (60.7) 17 (60.7)
No 11 (39.3) 11 (39.3)
Smoking habit 0.48f
Yes 4 (14.3) 6 (21.4)
No 24 (85.7) 22 (78.6)
Type of cancer 0.63g
Gastrointestinal 2 (25) 8 (28.6)
Leukemia 9 (32.1) 7 (25)
Lung 3 (10.7) 2 (7.1)
Bone 2 (7.1) 2 (7.1)
Kidney 1 (3.6) 5 (17.9)
Breast 6 (21.4) 4 (14.3)
Time of Cancer 0.76g
<12 months 21 (75) 20 (71.4)
>12 months 7 (25) 8 (28.6)
Chemotherapy regimens 0.84g
AMETABb 5 (17.9) 4 (14.3)
AMETAB þ AKc þ PDd 1 (3.6) 3 (10.7)
AMETAB þ AK þ AAe 4 (14.3) 3 (10.7)
AK þ AA 5 (17.9) 8 (28.6)
PD þ AK þ AA 4 (14.3) 4 (14.3)
PD þ AK 6 (21.4) 3 (10.7)
AMETAB þ AA 3 (10.7) 3 (10.7)
Chemotherapy cycles >0.99g
1e5 times 9 (32.1) 9 (32.1)
5e10 times 15 (53.6) 13 (46.4)
10e15 times 1 (3.6) 2 (7.1)
15e20 times 3 (10.7) 4 (14.3)
Receiving an Analgesic >0.99g
Yes 5 (17.8) 5 (17.8)
No 51 (82.2) 51 (82.2)
a All data are presented as n (%).
b Antimetabolites.
c Alkylating agents.
d Plant derivatives.
e Antitumor antibiotics.
f Chi-square.
g Fishers exact test.
Table 3
Comparison of mean severity of oral mucositis in the cancer patients who referred to
Shahid Beheshti Hospital, Kashan in 2013 in three observations.a
Severity of oral mucositis Group P valueb
Control Experimental
Before intervention 2.39 ± 0.87 2.39 ± 0.87 >0.99
Day 7 after receiving mouthwash 2.75 ± 0.88 1.07 ± 0.85 0.001
Day 14 after receiving mouthwash 2.89 ± 0.95 0.32 ± 0.54 0.001
P valuec 0.001 0.001 e
a All data presented as Mean ± SD.
b ManneWhitney U test.
c Friedman test.
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Study design and participants
This clinical trial study was conducted on cancer patients with
chemotherapy-induced OM referring to Shahid Beheshti Hospital
in Kashan, Iran, from September 2013 to January 2014.Table 2
Comparison of grading the severity of oral mucositis in the cancer patients who referred
Time
Before intervention Day 7 of
Severity of oral mucositis Experimental Control Experime
Grade zero 0 (0) 0 (0) 8 (28.6)
Grade 1 5 (17.9) 5 (17.9) 11 (39.3)
Grade 2 9 (32.1) 9 (32.1) 8 (28.6)
Grade 3 12 (42.9) 12 (42.9) 1 (3.6)
Grade 4 2 (7.1) 2 (7.1) 0 (0)
a All data are presented as n (%).The patients were under chemotherapy and received an anti-
inﬂammatory drug (Dexamethasone 8 mg) as well. Inclusion
criteria were as follows: having clinical signs of chemotherapy-
induced OM, being at age of 20 years old or over, complete con-
sciousness, having no history of allergy, allergic rhinitis and asthma,
no history of radiotherapy, and not receiving systemic antibiotic
and antifungal drugs. Exclusion criteria were receiving radio-
therapy during the study, fever, use of another mouthwash during
the study, patient's decision to leave the study, irregular use of
mouthwash in terms of time and amount, receiving systemic
antibiotic or antifungal drugs at beginning or during the study.
Sample size was calculated using the results of a local study
conducted by Shabanlouei et al. (2006), S1, S2, m1, and m2 were
respectively equal to 3.62, 6.95, 14.75, and 3.18 (Shabanlouei et al.,
2006). Accordingly, with a type I error of 0.05 and a power of 0.80,
the sample sizewas determined to be sevenpatients for each group.
However, for compensating probable attritions and achieving more
reliable results, we recruited 28 patients for each group.
In the present study, 56 patients with inclusion criteria were
entered the study consecutively and were randomly assigned into
control and experimental groups (each 28 patients) in similar
blocks based on OM severity. The randomization was performed
using a computer software. The Consort ﬂow diagram of the study
is presented in Fig. 1.
The routine mouthwash was prepared by adding 1400 mg of
Lidocaine, 224 mg of Dexamethasone, 35,000 mg of Sucralfate per
liter to a Diphenhydramine solution. The Diphenhydramine solu-
tion was purchased from Alborz Daroo Company, Ghazvin, Iran.
Control group received the routine mouthwash while patients in
the experimental group received a mixture of the routing mouth-
wash and A. millefolium distillate (50/50). To keep the study blind
from the patients and physician, both mouthwashes were prepared
in bottles with similar shape, size and color and then all bottles
were coded as “a” or “b.” The treating physician and the patients
were not aware of codes. Also, the nurses who gave the bottle to the
patients were not aware of codes. However, she documented the
name of patients and the codes of the bottles and passed it to the
researcher. In addition, the statistician who performed the data
analysis was kept blinded to the allocation, as well.to Shahid Beheshti Hospital, Kashan in 2013 in three observations.a
receiving mouthwash Day 14 of receiving mouthwash
ntal Control Experimental Control
0 (0) 20 (71.4) 0 (0)
2 (7.1) 7 (25) 2 (7.1)
9 (32.1) 1 (3.6) 8 (28.6)
11 (39.3) 0 (0) 9 (32.1)
6 (21.4) 0 (0) 9 (32.1)
Table 5
The relationship between oral mucositis severity and age, cigarette numbers per day
and Chemotherapy cycles carried out in cancer patients who referred to Shahid
Beheshti Hospital, Kashan in 2013.a
Group Age Cigarette
number
per day
Number of
chemotherapy
cycles
Experimental
Severity of oral mucositis before
intervention
0.05 0.27 0.14
Severity of oral mucositis in day 7 0.13 0.05 0.01
Severity of oral mucositis in day 14 0.08 e 0.03
Control
Severity of oral mucositis before
intervention
0.25 0.15 0.03
Severity of oral mucositis in day 7 0.27 0.25 0.04
Severity of oral mucositis in day 14 0.19 0.25 0.08
a All data presented as correlation coefﬁcient.
Fig. 2. Comparison of average severity of oral mucositis in the cancer patients who
referred to Shahid Beheshti Hospital, Kashan in 2013 in three observations.
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growing in the plains of Ardahal, Kashan, Iran by Barij Esans
Company, Kashan, Iran. In order to prepare 20 liters (L) of the
distillate, 10 kg of yarrow plant ﬂower with 50 L of water was boiled
in a boiler connected to a condenser placed in cold water. The entire
containers were from copper and the tubes from steel. The distillate
used in this study had a concentration of 12 ppm.
The patients participated in the study were trained individually,
how to perform mouth care, use of toothbrush and mouthwash.
Patients' feedbacks were used to make sure they understood the
provided information. All the patients were trained to wash their
hands four times a day (after every meal: breakfast, lunch, dinner,
and before going to bed), brush their teeth with a soft toothbrush
and toothpaste and then use mouthwash. According to the in-
struction, for 14 days, they had to hold 15 mL of the solution for
3 min in their mouth, gargle the solution and then discard it. They
were not allowed to wash their mouth or eat for an hour after
mouth washing.
The instruments
The data were collected using a three-part instrument. The ﬁrst
part consisted of questions on demographics, type of cancer,
chemotherapy information, and receiving an analgesic, smoking
habit and using artiﬁcial teeth. The second part of the instrument
was a checklist used to record the severity of OM at three times
before, 7 and 14 days after the intervention. This checklist was
based on the WHO criteria (2005) for assessment of OM severity as
follows: grade zero: no wound; grade 1: pain and erythema; grade
2: erythema and wound, but the patient could swallow solid foods;
grade 3: wound and extensive erythema, in this case the patientTable 4
Comparison of average severity of oral mucositis in both groups in the cancer pa-
tients who referred to Shahid Beheshti Hospital, Kashan in 2013 in three
observations.
Group Time Mean difference of oral
mucositis severity
P value
Experimental
Before
intervention
Day 7 after intervention 1.32 ± 0.13 0.001
Day 14 after intervention 2.07 ± 0.13 0.001
Day 7 after
intervention
Day 14 after intervention 0.75 ± 0.11 0.001
Control
Before
intervention
Day 7 after intervention 0.35 ± 0.09 0.002
Day 14 after intervention 0.50 ± 0.09 0.001
Day 7 after
intervention
Day 14 after intervention 0.14 ± 0.06 0.04could not eat solid foods; grade 4: stomatitis has been spread to an
extent that it could not be treated easily and eating is impossible.
The severity of OM was scored according to its grade (i.e. ranging
from zero to 4). The content validity and reliability of the Persian
version of checklist were conﬁrmed by Ashktorab et al. and its
inter-observer reliability was 0.93 (Ashktorab et al., 2010). The third
part of the instrument was another checklist for adherence moni-
toring. The checklist had 14 columns for each day one, and each
column with four rows (four times a day). The patients or one of
their companions were trained to mark the checklist. The
researcher reviewed the checklists and also monitored the contains
of the mouthwash bottles at seventh and fourteenth days and the
adherence was equal between both groups.Ethical considerations
The study was approved by the Research Council and Research
Ethics Committee of Kashan University of Medical Sciences, No.: P/
29/5/1/2571 dated 16 Sep. 2013. All the patients signed a written
informed consent before participation in the study; for illiterate
patients the form was read by the researcher. All the patients were
informed that participation in the study is voluntary and were
assured that their personal information would be treated conﬁ-
dentially. Researchers were committed to consider the participants'
rights in accordance to the principles explained in the Helsinki
Declaration.Data analysis
The data were analyzed using Statistical Package for Social Sci-
ences (SPSS, v. 11.5). Descriptive statistics were used to describe and
classify the data. Chi-square and Fisher's exact tests were used to
compare the two groups in terms of demographic information, type
of cancer, smoking habit, using artiﬁcial teeth, chemotherapy
regime, number of chemotherapy cycles and, receiving an analgesic
drug.
The Friedman (in each group) and ManneWhitney U tests (be-
tween two groups) were used to compare the stomatitis severity at
three times before, 7 and 14 days after intervention. Moreover, the
ManneWhitney U test was used to compare the mean scores of OM
severity in the two genders, in patients with and without smoking
habit, and in patients with and without artiﬁcial teeth. Further-
more, KruskaleWallis test was used to compare the severity of OM
in different cancer types and chemotherapy regimens. The
Spearman correlation coefﬁcient was also used to evaluate the
relationship between the severity of OM and number of
Table 6
Comparison of mean oral mucositis severity in terms of gender, artiﬁcial teeth, smoking habit and cancer type in cancer patients who referred to Shahid Beheshti Hospital,
Kashan in 2013.a
Group Severity of oral mucositis
Before intervention P value Day 7 P value Day 14 P value
Experimental
Gender 0.92b 0.86b 0.65b
Male 2.42 ± 0.90 1.08 ± 0.79 0.25 ± 0.45
Female 2.38 ± 0.88 1.06 ± 0.92 0.38 ± 0.61
Artiﬁcial teeth 0.23b 0.37b 0.43b
Yes 2.24 ± 0.90 0.94 ± 0.74 0.24 ± 0.43
No 2.64 ± 0.80 1.27 ± 1.01 0.45 ± 0.68
Smoking habit 0.60b 0.42b 0.18b
Yes 2.25 ± 0.5 0.75 ± 0.95 0.001 ± 0.001
No 2.42 ± 0.92 1.12 ± 0.85 0.38 ± 0.57
Type of cancer 0.73c 0.70c 0.47c
Gastrointestinal 2.63 ± 0.51 1.38 ± 0.74 0.50 ± 0.53
Leukemia 2.11 ± 1.05 0.89 ± 0.92 0.22 ± 0.44
Lung 2.33 ± 0.57 0.67 ± 0.57 0.01 ± 0.01
Bone 2.00 ± 10.41 1.00 ± 1.41 0.50 ± 0.70
Kidney e e e
Breast 2.67 ± 1.03 1.17 ± 0.98 0.33 ± 0.81
Control
Gender 0.92b 0.44b 0.35b
Male 2.42 ± 1.08 2.58 ± 1.08 2.67 ± 1.15
Female 2.38 ± 0.71 2.88 ± 0.71 3.06 ± 0.77
Artiﬁcial teeth 0.49b 0.60b 0.76b
Yes 2.29 ± 0.77 2.71 ± 0.68 2.88 ± 0.85
No 2.55 ± 1.03 2.82 ± 1.16 2.91 ± 1.13
Smoking habit 0.63b 0.54b 0.86b
Yes 2.50 ± 1.22 2.83 ± 1.47 2.83 ± 1.47
No 2.36 ± 0.79 2.73 ± 0.70 2.91 ± 0.81
Type of cancer 0.49c 0.44c 0.29c
Gastrointestinal 2.29 ± 0.75 2.57 ± 1.13 2.71 ± 1.11
Leukemia 2.57 ± 0.97 3.00 ± 0.81 3.14 ± 0.90
Lung 2.50 ± 0.70 3.00 ± 0.01 3.50 ± 0.70
Bone 3.00 ± 1.41 3.50 ± 0.70 3.50 ± 0.70
Kidney 1.83 ± 0.98 2.17 ± 0.75 2.17 ± 0.75
Breast 2.75 ± 0.50 3 ± 0.81 3.25 ± 0.95
a All data presented as Mean ± SD.
b ManneWhitney U.
c KruskaleWallis test.
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value less than 0.05 was considered signiﬁcant for all tests.
Results
The number of patients' participated in this study was 56. No
signiﬁcant difference was observed in terms of mean age between
the experimental (56.46 ± 14.32) and control group (55.54 ± 14.01)
(P ¼ 0.8). In total, 67.9% of the experimental group and 64.3% of the
control group were married. There was no signiﬁcant difference
between the two groups regarding artiﬁcial teeth, smoking habit,
type of cancer, chemotherapy regimens and other demographic
information (Table 1).
Before receiving the mouthwashes, 42.9% and 7.1% of the pa-
tients in control and experimental groups were in grade 3 or 4
OM, respectively. In the days 7 and 14 after the intervention, 3.6%
and 0% of the experimental group were in of grade 3 or 4 OM,
respectively. However, at this times, the rate of patients with grade
3 or 4 OM were increased to more than 60% in the control group
(Table 2).
The mean score of OM severity was equal (2.39 ± 0.87) in both
groups at the start of the study. The mean severity score of OM in
the experimental group was reduced to 1.07 ± 0.85 and 0.32 ± 0.54
in days 7 and 14 after the intervention, respectively (P
value< 0.001). However, in the control group, the mean severity
score of OM was increased to 2.75 ± 0.88 and 2.89 ± 0.95 in days 7
and 14, respectively (P value< 0.001) (Table 3 and Fig. 2).However, Friedman and Wilcoxon tests showed the signiﬁcant
differences (p < 0.001) between the mean severity score of OM in
control and experimental group at the three assessment times as
well (Tables 3 and 4).
The Spearman correlation coefﬁcient showed no signiﬁcant
relationship between the severity of OM and age, daily cigarette
smoking, or number of chemotherapy cycles (P > 0.05) (Table 5).
Also, the ManneWhitney U test certiﬁed that none of the factors
such as gender, dentures or smoking habits had any effect on
severity of OM before or during the study (Table 6). Although the
mean score of OM of women, especially in the control group was
higher than that in men but none of them were statistically sig-
niﬁcant. KruskaleWallis test showed no signiﬁcant difference be-
tween the mean score of OM severity in patients with different
types of cancer and chemotherapy regimens (Tables 6 and 7).
Discussion
The present study was designed to investigate the effect of
adding A. millefolium distillate on mouthwash on chemotherapy-
induced OM. In this study, the severity of OM was signiﬁcantly
reduced in the experimental group receiving the A. millefolium-
contained solution. It was interesting that more than 71% of the
patients in this group were completely healed at day 14 of the
experiment. No previous studies are available on using A. mil-
lefolium to treat OM due to cancer chemotherapy. However, ﬁnd-
ings of the present study was consistent with a study that used
Table 7
The comparison of mean and standard deviation of oral mucositis severity scores in terms of chemotherapy regimens.a
Chemotherapy regimens in the two groups Before intervention P valueb Day 7 P valueb Day 14 P valueb
Experimental 0.29 0.23 0.15
AMETAB 2.40 ± 0.54 1.20 ± 0.44 0.20 ± 0.44
AMETAB þ AK þ PD 3.00 ± 0 2.00 ± 0 1.00 ± 0
AMETAB þ AK þ AA 3.25 ± 0.50 1.75 ± 0.95 1.00 ± 0.81
AK þ AA 2.00 ± 1.22 0.80 ± 0.83 0.2 ± 0.44
PD þ AK þ AA 2.00 ± 0.81 0.25 ± 0.50 0.01 ± 0.001
PD þ AK 2.17 ± 0.98 1.00 ± 0.89 0.17 ± 0.40
AMETAB þ AA 2.67 ± 0.57 1.33 ± 1.15 0.33 ± 0.57
Control 0.26 0.51 0.40
AMETAB 2.00 ± 0.81 2.25 ± 0.50 2.50 ± 1.00
AMETAB þ AK þ PD 3.00 ± 1.00 3.00 ± 1.00 3.33 ± 1.15
AMETAB þ AK þ AA 2.67 ± 0.57 3.00 ± 1.00 3 ± 1.00
AK þ AA 2.38 ± 1.06 2.88 ± 0.99 3 ± 1.06
PD þ AK þ AA 2.75 ± 0.50 2.75 ± 0.50 2.75 ± 0.50
PD þ AK 1.33 ± 0.57 2.00 ± 1.00 2.00 ± 1.00
AMETAB þ AA 2.67 ± 0.57 3.33 ± 1.15 3.67 ± 0.57
a All data presented as Mean ± SD.
a Kruskal Wallis Test.
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herbal materials, including A. millefolium and reported that it was
effective in treating OM after hematopoietic stem cell trans-
plantation (Oberbaum et al., 2001). In another study, the healing
effects of A. millefolium on treatment of rats' gastric ulcer have been
conﬁrmed. This effect was attributed to the antibacterial and
healing properties of A. millefolium (Rashidi et al., 2005).
In the present study, the routine mouthwash used in cancer
clinic (which was a mixture of Lidocaine, Dexamethasone,
Sucralfate and Diphenhydramine) did not show any signiﬁcant
effect on the chemotherapy induced OM. Consequently, the
severity of OM was increased in the control group during the
experiment. In a recent study, it has reported that although Allo-
purinol, granulocyte growth factors, immunoglobulin's and herbal
extracts are effective but sucralfate, lidocaine, or diphenhydramine
had no effect in treating chemotherapy-induced OM (Clarkson
et al., 2008).
The ﬁndings of this study revealed that neither in the experi-
mental group nor in the control group, there was no signiﬁcant
relation between stomatitis severity and factors such as, gender,
age, and cancer type. However, some of previous studies have re-
ported that gender and age could affect the severity of chemo-
therapy induced OM so that females, older people and children are
more vulnerable to severe OM (Cheng et al., 2004; Eilers, 2004;
Vokurka et al., 2006). This discrepancy might be explained by the
fact that our patients did not include any children or very older
people. Beside, the different OM severity seen between men and
women is clinically important even though it was not statistically
signiﬁcant.
The ﬁndings of this study revealed that neither in experimental
group, nor in control group, there was no signiﬁcant difference
between the severity of OM in different chemotherapy regimens.
This ﬁnding may be attributed to the diversity of chemotherapy
regimens in our patients. Then a small number of patients were
under treatment with each type of regimen and this small number
was not enough to detect differences in the severity of OM.Limitations of the study
The small sample size, not studying other variables such as teeth
problems (decay, break, and implant), history of oral disease, and
white blood cell (WBC) count may limit the generalizability of the
ﬁndings. Also, if the patients' mouths were checked daily in order todetermine the treatment progress, more precise data would have
been generated.
Conclusion
Since the mixture of A. millefolium distillate with the routine
solution used in this study could decrease the severity of OM due to
chemotherapy and had no side effects, this solution might be used
for all patients during chemotherapy. Given the A. millefolium
distillate was mixed with ward's routine solution, it is suggested
that A. millefolium distillate alone be used to clearly deﬁne its effect
on improvement of OM. Also the mixture of A. millefolium distillate
with other types of mouthwash should be tested to optimize the
effect of this plant.
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